Reynders Mc Veigh Capital Management, LLC Gilead Sciences, Inc. Transaction History

Reynders Mc Veigh Capital Management, LLC

  • $1.89 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
SELL
$76.01 - $86.7 $21,434 - $24,449
-282 Reduced 7.13%
3,673 $283,000
Q1 2023

May 03, 2023
BUY
$77.31 - $88.08 $27,676 - $31,532
358 Added 9.95%
3,955 $328,000
Q4 2022

Feb 10, 2023
SELL
$62.32 - $89.47 $10,656 - $15,299
-171 Reduced 4.54%
3,597 $309,000
Q3 2022

Nov 08, 2022
BUY
$59.54 - $68.01 $10,181 - $11,629
171 Added 4.75%
3,768 $232,000
Q2 2022

Aug 05, 2022
BUY
$57.72 - $65.01 $207,618 - $233,840
3,597 New
3,597 $222,000
Q1 2022

May 11, 2022
SELL
$57.92 - $72.58 $179,262 - $224,635
-3,095 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$64.88 - $73.64 $41,782 - $47,424
-644 Reduced 17.22%
3,095 $225,000
Q3 2021

Nov 15, 2021
BUY
$67.69 - $73.03 $43,592 - $47,031
644 Added 20.81%
3,739 $261,000
Q2 2021

Aug 12, 2021
SELL
$63.47 - $69.35 $254,197 - $277,746
-4,005 Reduced 56.41%
3,095 $213,000
Q1 2021

May 07, 2021
SELL
$60.0 - $68.46 $15,720 - $17,936
-262 Reduced 3.56%
7,100 $459,000
Q4 2020

Feb 10, 2021
SELL
$56.65 - $64.55 $240,196 - $273,692
-4,240 Reduced 36.55%
7,362 $429,000
Q3 2020

Oct 28, 2020
SELL
$62.1 - $78.08 $90,293 - $113,528
-1,454 Reduced 11.14%
11,602 $733,000
Q2 2020

Aug 14, 2020
BUY
$72.34 - $84.0 $105,544 - $122,556
1,459 Added 12.58%
13,056 $1.01 Million
Q1 2020

May 13, 2020
SELL
$62.63 - $80.22 $5,887 - $7,540
-94 Reduced 0.8%
11,597 $867,000
Q4 2019

Feb 14, 2020
SELL
$61.62 - $67.78 $63,160 - $69,474
-1,025 Reduced 8.06%
11,691 $760,000
Q3 2019

Nov 08, 2019
SELL
$62.51 - $69.0 $625 - $690
-10 Reduced 0.08%
12,716 $806,000
Q2 2019

Aug 06, 2019
SELL
$61.87 - $69.38 $62,364 - $69,935
-1,008 Reduced 7.34%
12,726 $860,000
Q1 2019

May 10, 2019
SELL
$62.53 - $70.05 $315,526 - $353,472
-5,046 Reduced 26.87%
13,734 $893,000
Q4 2018

Feb 14, 2019
SELL
$60.54 - $79.0 $1.11 Million - $1.44 Million
-18,277 Reduced 49.32%
18,780 $1.18 Million
Q3 2018

Nov 26, 2018
SELL
$71.28 - $78.92 $2.95 Million - $3.27 Million
-41,374 Reduced 52.75%
37,057 $2.86 Million
Q2 2018

Aug 09, 2018
BUY
$64.88 - $75.68 $175,240 - $204,411
2,701 Added 3.57%
78,431 $5.56 Million
Q1 2018

Jul 26, 2018
BUY
$72.84 - $88.8 $5.1 Million - $6.22 Million
70,021 Added 1226.5%
75,730 $5.71 Million
Q1 2018

May 03, 2018
SELL
$72.84 - $88.8 $4.54 Million - $5.54 Million
-62,370 Reduced 91.61%
5,709 $75.7 Million
Q4 2017

Feb 06, 2018
BUY
$71.15 - $83.52 $1.41 Million - $1.65 Million
19,800 Added 41.01%
68,079 $0
Q3 2017

Nov 09, 2017
SELL
$72.11 - $85.47 $294,425 - $348,974
-4,083 Reduced 7.8%
48,279 $3.91 Million
Q2 2017

Aug 14, 2017
BUY
N/A
52,362
52,362 $3.71 Million

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email